drugset / Trial / NCT02242812
Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective was to show that telmisartan is not inferior to metoprolol succinate in respect of the percentage change from baseline in LVMI(H) after a 6.5 months treatment period. As secondary objectives, the improvement in left ventricular systolic and diastolic function and blood pressure reduction were assessed
Timeline
- Start
- 2003-09
- Primary completion
- 2004-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoprolol | Other / unclassified | 95 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |